
Press releases
Arseus attaches great importance to regular and transparent communication with its stakeholders. The publication of press releases plays an important role in this communication flow. All press releases will be available on this web site.
- 17-05-2013 :
Disclosure of acquisition of treasury shares - 14-05-2013 :
Annual General Meeting of Arseus approves all motions - 08-05-2013 :
Disclosure of acquisition of treasury shares - 30-04-2013 :
Publication of Guarantor List and Compliance Certificate - 30-04-2013 :
Disclosure of received notification - 25-04-2013 :
Acquisition of United States based Freedom Pharmaceuticals - 15-04-2013 :
Change to method of calculating turnover growth at constant exchange rates - 12-04-2013 :
Convocation to the annual general meeting of Arseus - 09-04-2013 :
Arseus turnover increases to € 133.3 million - 05-04-2013 :
Disclosure of acquisition of treasury shares - 04-04-2013 :
Disclosure of received notification - 27-03-2013 :
Disclosure of acquisition of treasury shares - 18-03-2013 :
Disclosure of acquisition of treasury shares - 07-03-2013 :
Disclosure of acquisition of treasury shares - 06-02-2013 :
EBIT increased 25.5% to € 58.1 million - 02-01-2013 :
Disclosure of acquisition of treasury shares